DJ Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ advanced 1.80% to $49.82 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 2.51% to 5,287.76 and the Dow Jones Industrial Average rising 2.66% to 39,186.98.
The stock's rise snapped a four-day losing streak.
Bristol Myers Squibb Co. closed 21.33% below its 52-week high of $63.33, which the company reached on March 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.53% to $157.75, Pfizer Inc. $(PFE)$ rose 2.22% to $22.53, and Abbott Laboratories $(ABT)$ rose 1.42% to $131.73.
Trading volume (11.9 M) remained 1.2 million below its 50-day average volume of 13.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 22, 2025 16:38 ET (20:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。